Defining Regorafenib as a Senomorphic Drug: Therapeutic Potential in the Age-Related Lung Disease Emphysema

Investigators reported the identification of regorafenib, an inhibitor of multiple receptor tyrosine kinases, as a senescence-attenuating drug.